Kazakhstan vs Oman: New cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Oman
100.0%
in 2024
Kazakhstan rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Kazakhstan
- Oman
How they compare
Kazakhstan currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 7 times across 19 shared years of data; in 2006 it was Kazakhstan ahead.
Kazakhstan ranks 1st and Oman ranks 1st of 192 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.0% | 65.2% | 7.8% | Kazakhstan |
| 2010s | 97.1% | 95.9% | 1.2% | Kazakhstan |
| 2020s | 100.0% | 91.2% | 8.8% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Kazakhstan or Oman?
- Kazakhstan, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Kazakhstan and Oman?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Oman?
- 19 years are reported by both, from 2006 to 2024.
- How do Kazakhstan and Oman rank globally for new cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.